55
Participants
Start Date
March 31, 2006
Primary Completion Date
November 30, 2008
Study Completion Date
May 31, 2009
bevacizumab
Bevacizumab 15 mg/kg every 3 weeks over 30 to 90 minutes. One cycle = 3 weeks. Treatment continues until progressive disease or unacceptable toxicity.
Hematology-Oncology Associates of Illinois, Chicago
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER